[ad_1] Moderna MRNA, +3.81% and Pfizer PFE, -0.41% have not yet started clinical trials for…
-
-
STOCK MARKET
Novavax’s protein-based vaccine approval fails to boost stock as demand for shots and boosters remains low
[ad_1] U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
-
STOCK MARKET
New omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5
[ad_1] A new, highly infectious subvariant of omicron is raising concerns among scientists and health…
-
[ad_1] The U.S. should pursue a COVID-19 booster strategy that focuses on developing new shots…
-
STOCK MARKET
Biden appears to lean toward gas tax holiday, pushes back after Chevron says oil industry has been vilified
[ad_1] President Joe Biden on Tuesday offered signs that he could support suspending the federal gasoline…
-
STOCK MARKET
U.S. to start vaccinating very young children this week, and panel to recommend overhauling health care system
[ad_1] The U.S. will start vaccinating children below the age of 5 starting this week,…
-
STOCK MARKET
U.S. government is offering free COVID tests again, as cases rise 57% from two weeks ago
[ad_1] The federal government is again offering Americans free COVID-19 test kits through the mail,…
-
[ad_1] COVID-19 cases and hospitalizations are rising as part of what some are referring to…
-
[ad_1] Pfizer PFE, +0.75% is already laying the groundwork for what the pharmaceutical behemoth will…
-
STOCK MARKET
Pandemic is not over yet, says Dr. Fauci, and WHO says omicron accounted for 99.7% of all cases sequenced in latest week
[ad_1] Just hours after saying the U.S. was out of the “pandemic phase,” Dr. Anthony…
